针对静脉瘤疾病的抗血栓治疗:CHEST指南2012-2021年综合和综述
Scott M Stevens1, Scott C Woller1, Lisa Baumann Kreuziger2
1Department of Medicine, Intermountain Health, Murray, UT; Department of Internal Medicine, Univeristy of Utah School of Medicine, Salt Lake City, UT.
Chest
|March 8, 2024
概括
本综述整合了来自美国胸腔医师学院 (CHEST) 更新的指导方针中的58个关于静脉血栓栓塞 (VTE) 疾病抗血栓治疗的关键指导陈述. 它为当前的临床实践和未来的更新提供了一个统一的资源.
科学领域:
- 医学指导方针 医学指导方针
- 血栓形成的管理
- 基于证据的医学基于证据的医学.
背景情况:
- 静脉血栓塞栓症 (VTE) 疾病的抗血栓治疗指南经常更新.
- 以前的指导声明分散在多个出版物中.
- 为了临床实践,需要统一收集当前的相关陈述.
研究的目的:
- 巩固和审查目前关于VTE疾病抗血栓治疗的指导声明.
- 识别与当代临床护理相关的陈述.
- 为临床医生提供一个单一的,可访问的资源.
主要方法:
- 一个国际专家小组审查了之前的CHEST抗血栓治疗指南和更新.
- 一个经过修改的Delphi过程选择了相关的指导语句.
- 声明的措辞改写,使用推,评估,发展和评估 (GRADE) 格式的分级.
主要成果:
- 包含了来自之前指南的58个指导声明,并更新了措辞.
- 根据GRADE方法,声明被分类为强或弱的建议.
- 五个陈述被认为不再与当前实践相关.
结论:
- 这篇文章介绍了目前针对静脉瘤疾病的相关抗血栓治疗指导声明的统一集合.
- 合并报表遵循当代的分类法和GRADE方法.
- 根据新出现的证据,为未来的指南更新提供了建议.
相关概念视频
Flail Chest-II
169
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
169
Anticoagulant Drugs: Low-Molecular-Weight Heparins
696
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
696
Pneumothorax-II
145
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
145
Esophageal Varices-II: Clinical Features and Management
66
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
66
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
181
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K


